ArticleFrontiers in aging2026
Vitamin D, systemic inflammation, and motoric cognitive risk: exploring the risk factors and mediation pathways.
Article in Frontiers in aging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Motoric cognitive risk (MCR) syndrome, defined by subjective cognitive complaints and slow gait, is a predementia condition associated with multiple adverse outcomes. Although vitamin D deficiency and systemic inflammation have been implicated in cognitive and motor decline, their interaction in the context of MCR remains unclear. Methods: This cross-sectional study included 312 hospitalized adults aged ≥60 years. Serum 25(OH)D levels, systemic immune-inflammation index (SII), and standardized clinical assessments were obtained within 48 h of admission. Multivariable regression and mediation analyses were performed to evaluate associations and underlying pathways. Results: The prevalence of MCR was 17.9%. Older age, greater comorbidity burden, poor sleep quality, lower 25(OH)D levels, and higher SII were independently associated with MCR. Mediation analysis showed that systemic inflammation accounted for approximately one-quarter of the association between lower 25(OH)D and higher MCR risk, with the strongest indirect effect observed at 25(OH)D ≤ 20 ng/mL. Discussion: Vitamin D deficiency and systemic inflammation are important determinants of MCR. The identified vitamin D-inflammation pathway may contribute to motoric cognitive vulnerability and provide insights for early risk stratification and preventive strategies in geriatric populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.